Modern Chinese Medicine Group Co., Ltd. (1643.HK)
HKD 0.37
(2.82%)
HKD 0.37
(2.82%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 528.53 Million CNY | 5.38% |
| 2022 | 501.53 Million CNY | 26.67% |
| 2021 | 395.94 Million CNY | 89.21% |
| 2020 | 209.25 Million CNY | 69.98% |
| 2019 | 123.11 Million CNY | -28.84% |
| 2018 | 173.01 Million CNY | 48.84% |
| 2017 | 116.24 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 498.95 Million CNY | 0.0% |
| 2024 Q1 | 498.95 Million CNY | -5.6% |
| 2023 Q1 | 499.5 Million CNY | -0.41% |
| 2023 FY | 528.53 Million CNY | 5.38% |
| 2023 Q4 | 528.53 Million CNY | 0.0% |
| 2023 Q3 | 528.53 Million CNY | 5.81% |
| 2023 Q2 | 499.5 Million CNY | 0.0% |
| 2022 Q1 | 429.18 Million CNY | 8.4% |
| 2022 Q4 | 501.53 Million CNY | 0.0% |
| 2022 FY | 501.53 Million CNY | 26.67% |
| 2022 Q2 | 429.18 Million CNY | 0.0% |
| 2022 Q3 | 501.53 Million CNY | 16.86% |
| 2021 Q4 | 395.94 Million CNY | 0.0% |
| 2021 Q3 | 395.94 Million CNY | 13.97% |
| 2021 Q2 | 347.42 Million CNY | 0.0% |
| 2021 FY | 395.94 Million CNY | 89.21% |
| 2021 Q1 | 347.42 Million CNY | 66.03% |
| 2020 Q4 | 209.25 Million CNY | 18.71% |
| 2020 FY | 209.25 Million CNY | 69.98% |
| 2020 Q3 | 176.27 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q4 | 123.11 Million CNY | 0.0% |
| 2019 FY | 123.11 Million CNY | -28.84% |
| 2018 FY | 173.01 Million CNY | 48.84% |
| 2017 FY | 116.24 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 50.95 Billion HKD | 98.963% |